Mallinckrodt (MNK) Stock Rating Reaffirmed by Goldman Sachs Group

Mallinckrodt (NYSE:MNK)‘s stock had its “hold” rating reaffirmed by equities research analysts at Goldman Sachs Group in a research report issued on Monday.

A number of other analysts have also recently weighed in on the stock. Canaccord Genuity set a $24.00 target price on shares of Mallinckrodt and gave the stock a “hold” rating in a research note on Monday. Cantor Fitzgerald set a $42.00 price objective on shares of Mallinckrodt and gave the stock a “buy” rating in a research note on Monday. ValuEngine cut shares of Mallinckrodt from a “buy” rating to a “hold” rating in a research note on Sunday. Wells Fargo & Co reissued a “hold” rating on shares of Mallinckrodt in a research note on Tuesday, December 26th. Finally, Barclays set a $23.00 price objective on shares of Mallinckrodt and gave the stock a “hold” rating in a research note on Tuesday, December 12th. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and seven have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $47.64.

Shares of Mallinckrodt (MNK) opened at $23.52 on Monday. The firm has a market cap of $2,230.00, a price-to-earnings ratio of -1,176.00, a price-to-earnings-growth ratio of 0.41 and a beta of 1.30. Mallinckrodt has a one year low of $19.00 and a one year high of $55.32. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.05 and a current ratio of 1.38.

Mallinckrodt (NYSE:MNK) last posted its earnings results on Tuesday, November 7th. The company reported $1.97 earnings per share for the quarter, topping analysts’ consensus estimates of $1.80 by $0.17. The firm had revenue of $793.90 million for the quarter, compared to analysts’ expectations of $808.93 million. Mallinckrodt had a net margin of 11.43% and a return on equity of 14.79%. The company’s revenue was down 10.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.04 earnings per share. sell-side analysts expect that Mallinckrodt will post 7.2 EPS for the current year.

In other news, CEO Mark Trudeau purchased 5,000 shares of the business’s stock in a transaction on Friday, November 10th. The shares were acquired at an average price of $22.28 per share, with a total value of $111,400.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director David R. Carlucci purchased 10,000 shares of the business’s stock in a transaction on Thursday, November 9th. The shares were purchased at an average cost of $21.83 per share, for a total transaction of $218,300.00. Following the transaction, the director now directly owns 26,020 shares of the company’s stock, valued at approximately $568,016.60. The disclosure for this purchase can be found here. Insiders have acquired 30,460 shares of company stock worth $659,486 in the last ninety days. Insiders own 0.53% of the company’s stock.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Sentry Investment Management LLC raised its holdings in shares of Mallinckrodt by 1.6% during the second quarter. Sentry Investment Management LLC now owns 52,676 shares of the company’s stock valued at $2,360,000 after purchasing an additional 817 shares during the period. QS Investors LLC raised its holdings in shares of Mallinckrodt by 10.8% during the second quarter. QS Investors LLC now owns 9,477 shares of the company’s stock valued at $425,000 after purchasing an additional 923 shares during the period. Accident Compensation Corp raised its holdings in shares of Mallinckrodt by 2.7% during the second quarter. Accident Compensation Corp now owns 38,390 shares of the company’s stock valued at $1,720,000 after purchasing an additional 1,000 shares during the period. Commerzbank Aktiengesellschaft FI raised its holdings in shares of Mallinckrodt by 2.3% during the second quarter. Commerzbank Aktiengesellschaft FI now owns 57,894 shares of the company’s stock valued at $2,594,000 after purchasing an additional 1,286 shares during the period. Finally, Meiji Yasuda Life Insurance Co raised its holdings in shares of Mallinckrodt by 18.6% during the second quarter. Meiji Yasuda Life Insurance Co now owns 8,290 shares of the company’s stock valued at $371,000 after purchasing an additional 1,300 shares during the period. 97.35% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This report was originally published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://www.chaffeybreeze.com/2018/01/03/mallinckrodt-mnk-stock-rating-reaffirmed-by-goldman-sachs-group-2.html.

Mallinckrodt Company Profile

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs.

Analyst Recommendations for Mallinckrodt (NYSE:MNK)

Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply